Back
Aclaris Therapeutics Vs. CytomX Therapeutics Industry Stock Comparison
Sell
6
ACRS
Aclaris Therapeutics
Last Price:
1.22
Seasonality Move:
4.39%
Sell
16
CTMX
CytomX Therapeutics
Last Price:
1.64
Seasonality Move:
-13.94%
Sell
6
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.21. The Score for ACRS is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
- ACRS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
16
CytomX Therapeutics (CTMX)
is a Sell
Is CytomX Therapeutics a Buy, Sell or Hold?
- The current CytomX Therapeutics [CTMX] share price is $1.64. The Score for CTMX is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- CTMX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.21
The current trend is relatively stagnant and ACRS is experiencing slight buying pressure.
CTMX Stock Price Chart
What is CytomX Therapeutics's stock price today?
-
The CytomX Therapeutics share price today is $1.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTMX is experiencing slight buying pressure.
ACRS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 49.73 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.19 - 1.25) | Sell |
Bollinger Bands (100): | (1.07 - 1.27) | Buy |
CTMX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 31.95 | Sell |
Chaikin Money Flow: | 94168 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.7 - 2.14) | Sell |
Bollinger Bands (100): | (1.42 - 2.16) | Sell |
ACRS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.21 | Sell |
20-day SMA: | 1.21 | Sell |
50-day SMA: | 1.22 | Sell |
200-day SMA: | 3.67 | Sell |
8-day EMA: | 1.21 | Buy |
20-day EMA: | 1.21 | Sell |
50-day EMA: | 1.25 | Sell |
200-day EMA: | 3.58 | Sell |
CTMX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.64 | Sell |
20-day SMA: | 1.86 | Sell |
50-day SMA: | 2.05 | Sell |
200-day SMA: | 1.6 | Buy |
8-day EMA: | 1.66 | Sell |
20-day EMA: | 1.81 | Sell |
50-day EMA: | 1.89 | Sell |
200-day EMA: | 1.74 | Sell |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.06 per share, an increase this year of $0.55 per share, and an increase next year of $0.30 per share.
CytomX Therapeutics Earnings Growth & CTMX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.24 per share, and a decrease next year of $0.19 per share.
Aclaris Therapeutics Technical Analysis
Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CytomX Therapeutics Technical Analysis
Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |